ARCHIVES

Institutions Required To Review For Bias under PHS Proposal

This article is from The Cancer Letter archive.

Vol. 20 No. 29 | July 22, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

March Dedicated To Colorectal Cancer Awareness; New Advocacy Group.

March 10, 2000

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

IOM Report Lists Cancer CER Priorities

July 3, 2009

In Brief: Margaret Holms Names Centers Branch Chief; Kimes To Recruit As Special Assistant

March 30, 1990